Kohjin Bio Co., Ltd.

¥684.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:177AHealthcare
Country Japan
PE (Fwd) •••
TSR 3Y CAGR (32.51%)
Div yield 1.46%
ROE 2.21%
Biotechnology
Beta (5Y) 0.02
PE TTM 27.32
TSR TTM (55.18%)
Mkt cap ¥3.496B
ROIC 2.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥793
15.92%
(56.97%)
Hold 0|11|12|2|2
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
9.77
10.26
10.15
11.05
2.45%
9.68%
11.05%
25.74%
Revenue¥M
182.2
180.4
181.7
180.3
5.46%
0.52%
(1.09%)
0.45%
Peers (US$22.20M)
Cap (US$)
PE
20.83M
99.41x
21.97M
17.86x
Capital
TTM
5Y
10Y
Leveragex
3.024
0.442
0.439
EBIT/Intx
1.772
0.220
0.218
Own earn%
32.64
(72.90)
(62.58)
Sh yield%
32.07
14.79
13.91
Owners
Insiders/Inst%
1.60
45.05
Short interest%
3.41
SBC / revenue%
4.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
21–28
$1 testx
0.0
Incr. ROIC%
9